Experiment 394632

Worktypes

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismGinkgo biloba (GINKGOACEAE)
CitationHALAMA,P: BARTSCH,G: MENG,G:. (1988). DISTURBANCES OF CEREBRAL PERFORMANCE OF VASCULAR ORIGIN.. 106(19)
Amount utilized
Compound isolated
DiseaseTHE EFFICACY OF GINKGO BILOBA EXTRACT ON THE SYMPTOMS WAS TESTED IN 40 OUT-PATIENTS WITH THE DIAGNOSIS OF "MILD TO MEDIUM CEREBROVASCULAR INSUFFICIENCY" (DOSAGE: 1 FILM-COATED TABLET, 40 MG EXTRACT T.I.D., DURATION OF TREATMENT 12 WEEKS) IN A RANDOMIZED, PLACEBOCONTROLLED, DOUBLEBLIND TRIAL. IN THE GROUP RECEIVING GINKGO, THE VALUES FOR TATAL SCAG SCORE (SANDOZ CLINICAL ASSESSMENT-GERIATRIC) DROPPED ON AVERAGE BY 9 POINTS, WHEREAS THEY REMAINED UNCHANGED IN THE PLACEBO GROUP. (P = 0.00005). EVALUATION OF THE SEPARATE ITEMS SHOWED AN EFFECT PARTICULARLY ON DISTURBANCES OF SHORT-TERM MEMORY AND MENTAL AWARENESS AS WELL AS ON DIZZINESS AS A SYMPTOM. SUPERIOR EFFECTS WERE ALSO SHOWN IN THE SYMPTOMS OF HEADACHES AND TINNITUS (NOISE IN THE EARS), AS WELL AS THROUGH SYNDROME KURZTEST.
Dose amount120.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE
ExtractETOH(100%)EXT
GenderGIVEN TO BOTH SEXES